Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma
This study is ongoing, but not recruiting participants.
Study NCT01175109
Information provided by University of Virginia
First Received on July 28, 2010.
Last Updated on December 26, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
